Jeffrey M. Goldberg's most recent trade in Aeglea BioTherapeutics Inc was a trade of 1,884,838 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 29, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics Inc | Jeffrey M. Goldberg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2022 | 1,884,838 | 1,884,838 | - | - | Employee Stock Option (right to buy) |